ACE and congestive heart failure: This paper examines the rationale for combining a beta-blocker with an angiotensin-converting enzyme (ACE) inhibitor, at each stage of the CVD continuum, from individuals with cardiovascular risk factors to patients with chronic heart failure (Fig. 1).